Pages that link to "Q33940712"

The following pages link to Atomic basis of CRM1-cargo recognition, release and inhibition (Q33940712):

Displaying 43 items.

• Molecular Characterization and Functional Analysis of Annulate Lamellae Pore Complexes in Nuclear Transport in Mammalian Cells. (Q30362076) (← links)
• Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma (Q33434141) (← links)
• Nucleo-cytoplasmic transport as a therapeutic target of cancer (Q34452108) (← links)
• LocNES: a computational tool for locating classical NESs in CRM1 cargo proteins (Q35541125) (← links)
• Leukemia-Associated Mutations in Nucleophosmin Alter Recognition by CRM1: Molecular Basis of Aberrant Transport (Q35668674) (← links)
• Novel reversible selective inhibitor of CRM1 for targeted therapy in ovarian cancer (Q35732942) (← links)
• The Cellular Distribution of RanGAP1 Is Regulated by CRM1-Mediated Nuclear Export in Mammalian Cells (Q35823090) (← links)
• Nuclear export inhibitors avert progression in preclinical models of inflammatory demyelination (Q35910495) (← links)
• Ranbp1, Deleted in DiGeorge/22q11.2 Deletion Syndrome, is a Microcephaly Gene That Selectively Disrupts Layer 2/3 Cortical Projection Neuron Generation. (Q36098844) (← links)
• Structural determinants of nuclear export signal orientation in binding to exportin CRM1. (Q36132392) (← links)
• CRM1/XPO1 is associated with clinical outcome in glioma and represents a therapeutic target by perturbing multiple core pathways (Q37330941) (← links)
• Selective inhibitors of nuclear export (SINE)--a novel class of anti-cancer agents (Q38260357) (← links)
• Selective inhibitors of nuclear export (SINE) in hematological malignancies (Q38368605) (← links)
• Mechanisms Regulating Protein Localization. (Q38546818) (← links)
• Inhibition of CRM1-mediated nuclear export of influenza A nucleoprotein and nuclear export protein as a novel target for antiviral drug development (Q38708072) (← links)
• Breakthrough therapies in B-cell non-Hodgkin lymphoma. (Q38708600) (← links)
• Tubby family proteins are adapters for ciliary trafficking of integral membrane proteins (Q38718216) (← links)
• Anti-tumor activity of selective inhibitor of nuclear export (SINE) compounds, is enhanced in non-Hodgkin lymphoma through combination with mTOR inhibitor and dexamethasone (Q38738390) (← links)
• A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia. (Q38881093) (← links)
• CRM1 Inhibitors for Antiviral Therapy (Q39431526) (← links)
• A cellular reporter to evaluate CRM1 nuclear export activity: functional analysis of the cancer-related mutant E571K. (Q39677170) (← links)
• Structural snapshot of cytoplasmic pre-60S ribosomal particles bound by Nmd3, Lsg1, Tif6 and Reh1. (Q41382245) (← links)
• Karyopherin-β2 Recognition of a PY-NLS Variant that Lacks the Proline-Tyrosine Motif. (Q42386471) (← links)
• XPO1 target occupancy measurements confirm the selinexor recommended phase 2 dose (Q47113773) (← links)
• Verdinexor Targeting of CRM1 is a Promising Therapeutic Approach against RSV and Influenza Viruses (Q47549703) (← links)
• Karyopherins in cancer (Q50134836) (← links)
• Caffeic acid phenethyl ester (CAPE) revisited: Covalent modulation of XPO1/CRM1 activities and implication for its mechanism of action. (Q51318022) (← links)
• Nuclear Import Receptor Inhibits Phase Separation of FUS through Binding to Multiple Sites. (Q52314205) (← links)
• Nuclear export of ubiquitinated proteins via the UBIN-POST system. (Q52318700) (← links)
• Mapping regions in Ste5 that support Msn5-dependent and -independent nuclear export. (Q53190949) (← links)
• Exportin Crm1 is repurposed as a docking protein to generate microtubule organizing centers at the nuclear pore. (Q55412292) (← links)
• Give me a SINE: how Selective Inhibitors of Nuclear Export modulate autophagy and aging (Q60105214) (← links)
• Therapeutic Targets for Bone and Soft-Tissue Sarcomas (Q60920826) (← links)
• CRISPR-Cas9 Screening of Kaposi's Sarcoma-Associated Herpesvirus-Transformed Cells Identifies XPO1 as a Vulnerable Target of Cancer Cells (Q64056346) (← links)
• Distinct RanBP1 nuclear export and cargo dissociation mechanisms between fungi and animals (Q64088188) (← links)
• The past, present, and future of CRM1/XPO1 inhibitors (Q64107227) (← links)
• Crm1 knockdown by specific small interfering RNA reduces cell proliferation and induces apoptosis in head and neck cancer cell lines. (Q64967545) (← links)
• Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials (Q89866288) (← links)
• Selinexor in combination with decitabine in patients with acute myeloid leukemia: results from a phase 1 study (Q90214125) (← links)
• Phase 2 study of the Exportin 1 inhibitor selinexor in patients with recurrent gynecological malignancies (Q91852090) (← links)
• Targeting nuclear import and export in hematological malignancies (Q97093743) (← links)
• The nuclear export protein XPO1 - from biology to targeted therapy (Q101564368) (← links)
• The abnormal expression of chromosomal region maintenance 1 (CRM1)-survivin axis in ovarian cancer and its related mechanisms regulating proliferation and apoptosis of ovarian cancer cells (Q112348782) (← links)